Drugplain

BOBBI BROWN PRIMER PLUS PROTECTION BROAD SPECTRUM SPF50 30 mg/mL

AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE,AND OXYBENZONE · CREAM · Bobbi Brown Professional Cosmetics Inc.

No Recall History
Plain English

BOBBI BROWN PRIMER PLUS PROTECTION BROAD SPECTRUM SPF50 is a cream containing avobenzone,homosalate,octisalate,octocrylene,and oxybenzone at 30 mg/mL, taken topical. Manufactured by Bobbi Brown Professional Cosmetics Inc..

Key Facts

Brand Name
BOBBI BROWN PRIMER PLUS PROTECTION BROAD SPECTRUM SPF50
Generic Name
AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE,AND OXYBENZONE
NDC Code (Product)
64141-035
Manufacturer
Bobbi Brown Professional Cosmetics Inc.
Strength
30 mg/mL
Dosage Form
CREAM
Route
TOPICAL
Marketing Status
Application #
M020
Marketing Start
08/18/2023

Recall History

No Recall History

Frequently Asked Questions

What is BOBBI BROWN PRIMER PLUS PROTECTION BROAD SPECTRUM SPF50 used for?

BOBBI BROWN PRIMER PLUS PROTECTION BROAD SPECTRUM SPF50 contains AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE,AND OXYBENZONE. It is a cream taken topical. Consult your doctor for specific uses.

Is BOBBI BROWN PRIMER PLUS PROTECTION BROAD SPECTRUM SPF50 a controlled substance?

BOBBI BROWN PRIMER PLUS PROTECTION BROAD SPECTRUM SPF50 is not classified as a controlled substance by the DEA.

What is the generic name for BOBBI BROWN PRIMER PLUS PROTECTION BROAD SPECTRUM SPF50?

The generic name for BOBBI BROWN PRIMER PLUS PROTECTION BROAD SPECTRUM SPF50 is AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE,AND OXYBENZONE. There are no other listed brand versions of AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE,AND OXYBENZONE.

What is the NDC code for BOBBI BROWN PRIMER PLUS PROTECTION BROAD SPECTRUM SPF50 30 mg/mL?

The NDC (National Drug Code) for BOBBI BROWN PRIMER PLUS PROTECTION BROAD SPECTRUM SPF50 30 mg/mL is 64141-035, listed by Bobbi Brown Professional Cosmetics Inc..

Product NDC

64141-035

Package NDC

64141-035-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)